Therefore, although similar pathways are inhibited/activated in the MCF-10A and TNBC cells (Supplemental Figs. S4 and S5), the Hsp90β-selective inhibitors appear to exhibit selectivity for cancer cell lines. Here, HSP90AB1 is linked to cancer.